266
Views
13
CrossRef citations to date
0
Altmetric
Basic Research

Sodium butyrate-induced apoptosis and ultrastructural changes in MCF-7 breast cancer cells

, BS, , MS, , BS, , BS, , BS, , MD & , MD, PhD show all
Pages 200-204 | Received 08 Nov 2015, Accepted 21 Mar 2016, Published online: 09 May 2016

References

  • Li L, Sun Y, Liu J, et al. Histone deacetylase inhibitor sodium butyrate suppresses DNA double strand break repair induced by etoposide more effectively in MCF-7 cells than in HEK293 cells. BMC Biochem 2015;16:2–11.
  • Chao OS, Goodman OB, Jr. Synergistic loss of prostate cancer cell viability by coinhibition of HDAC and PARP. Mol Cancer Res Dec 2014;12(12):1755–1766.
  • Falkenberg KJ, Johnstone RW. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov Sep 2014;13(9):673–691.
  • Xiong F, Mou YZ, Xiang XY. Inhibition of mouse B16 melanoma by sodium butyrate correlated to tumor associated macrophages differentiation suppression. Int J Clin Exp Med 2015;8(3):4170–4174.
  • Demary K, Wong L, Spanjaard RA. Effects of retinoic acid and sodium butyrate on gene expression, histone acetylation and inhibition of proliferation of melanoma cells. Cancer Lett Feb 10 2001;163(1):103–107.
  • Jazirehi AR. Regulation of apoptosis-associated genes by histone deacetylase inhibitors: Implications in cancer therapy. Anticancer Drugs Oct 2010;21(9):805–813.
  • Chao H, Wang L, Hao J, et al. Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro. Cancer Lett Feb 1 2013;329(1):17–26.
  • Khabele D. The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer. Front Oncol 2014;4:111–119.
  • Lee JH, Choy ML, Ngo L, Foster SS, Marks PA. Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair. Proc Natl Acad Sci USA Aug 17 2010;107(33):14639–14644.
  • Greenberg VL, Williams JM, Boghaert E, Mendenhall M, Ain KB, Zimmer SG. Butyrate alters the expression and activity of cell cycle components in anaplastic thyroid carcinoma cells. Thyroid Jan 2001;11(1):21–29.
  • Chopin V, Toillon RA, Jouy N, Le Bourhis X. Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells. Br J Pharmacol Jan 2002;135(1):79–86.
  • Archer SY, Johnson J, Kim HJ, et al. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells. Am J Physiol Gastrointest Liver Physiol Oct 2005;289(4):G696–703.
  • Kuang CC, Wang Y, Hu PC, et al. Ritonavir-induced hepatotoxicity and ultrastructural changes of hepatocytes. Ultrastruct Pathol Oct 2014;38(5): 329–334.
  • Caruso RA, Rigoli L, Parisi A, et al. Neutrophil-rich gastric carcinomas: Light and electron microscopic study of 9 cases with particular reference to neutrophil apoptosis. Ultrastruct Pathol May 2013;37(3):164–170.
  • Tor YS, Yazan LS, Foo JB, et al. Induction of apoptosis through oxidative stress-related pathways in MCF-7, human breast cancer cells, by ethyl acetate extract of Dillenia suffruticosa. BMC Complement Altern Med 2014;14:55–67.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.